Tagged Articles

scopolamine 2 articles

Change.org petition urges FDA to add severe withdrawal warnings to motion sickness patch

The wife of a man who suffers recurrent severe withdrawal symptoms from a transdermal patch used to treat motion sickness has started a petition on Change.org to urge the Food and Drug Administration (FDA) to add new warnings to the safety label regarding long-term use, and to raise awareness of the need for further medical research into severe adverse reactions with longer-than-recommended use of the drug. The petition targets the brand name skin patch TransdermScop as well as any other form of scopolamine. The medication is approved by the FDA to treat motion sickness and postoperative nausea and vomiting. It ... Read More

Motion sickness patch recalled due to error in dosing instructions

Transderm Scop, a drug patch made by Sandoz used to treat motion sickness and post operative nausea and vomiting, and to decrease saliva before some surgeries, is being recalled because of incorrect dosage language on the product’s carton. The error is listed under Step 2 of the Dosage Administration sect, which erroneously states, “Use only one patch at a time. Do cut the patch.” The correct instructions should read, “Use only one patch at a time. Do not cut the patch.” The product’s pouch, physician insert, and patient inserts are labeled correctly. The patch contains the active ingredient scopolamine. Cutting ... Read More